Treatment of peripheral T-cell lymphomas: recommendations of the Belgian Hematological Society (BHS).

peer reviewed ; The sub-committee on lymphoproliferative disorders of the Belgian Hematological Society has met several times to prepare guidelines on the management of patients with peripheral T-cell lymphomas. Each panellist's expert provided interpretation of the evidence, based on literature review and personal experience. The available evidence was systematically discussed prior to formulating recommendations. A systematic approach to obtain consensus of expert opinion was used. After each meeting, the draft guideline was circulated to all experts for comment and approval. The present gui... Mehr ...

Verfasser: Van Obbergh, F.
Van Hoof, A.
Verhoef, G.
Dierickx, D.
De Wilde, V.
Offner, F.
Bron, D.
Sonet, A.
André, M.
Janssens, A.
Bonnet, Christophe
DE PRIJCK, Bernard
Zachée, P.
Kentos, A.
Schroyens, W.
Van Den Neste, E.
Dokumenttyp: journal article
Erscheinungsdatum: 2013
Verlag/Hrsg.: Ariez Medical Publishing
Schlagwörter: non-Hodgkin lymphoma / NK-cell neoplasm / peripheral T-cell lymphoma / T-cell neoplasm / Human health sciences / Hematology / Sciences de la santé humaine / Hématologie
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28888564
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://orbi.uliege.be/handle/2268/159981

peer reviewed ; The sub-committee on lymphoproliferative disorders of the Belgian Hematological Society has met several times to prepare guidelines on the management of patients with peripheral T-cell lymphomas. Each panellist's expert provided interpretation of the evidence, based on literature review and personal experience. The available evidence was systematically discussed prior to formulating recommendations. A systematic approach to obtain consensus of expert opinion was used. After each meeting, the draft guideline was circulated to all experts for comment and approval. The present guidelines focus on general management of peripheral T-cell lymphomas with special emphasis on more specific disease-adapted stratégies.